Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-18 Sale |
2025-03-20 9:48 pm |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
3,724 | $47.88 | $178,306 | 22,431 (Direct) |
View |
| 2024-06-18 Sale |
2024-06-20 4:26 pm |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
10,445 | $27.47 | $286,924 | 101,780 (Direct) |
View |
| 2022-10-05 Sale |
2022-10-06 4:15 pm |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
26,739 | $0 | $0 | 0 (Direct) |
View |
| 2022-09-01 Sale |
2022-09-06 7:00 pm |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
31,441 | $68 | $2,137,988 | 32,360 (Direct) |
View |
| 2020-07-13 Sale |
2020-07-15 5:11 pm |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
15,208 | $75 | $1,140,600 | 3,048 (Direct) |
View |
| 2020-06-09 Sale |
2020-06-11 4:06 pm |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
15,208 | $67 | $1,018,936 | 18,256 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-17 Exercise |
2025-03-18 9:40 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
16,038 | $0 | 50,215 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:19 pm |
N/A 2035-03-04 |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
50,717 | $0 | 50,717 (Direct) |
View |
| 2024-06-17 Exercise |
2024-06-20 4:26 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
27,881 | $0 | 101,780 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 5:11 pm |
N/A 2034-03-06 |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
79,579 | $0 | 79,579 (Direct) |
View |
Ownership(A) |
2023-04-28 8:01 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
0 | $0 | 700 (Direct) |
View |
| 2023-04-24 Option Award |
2023-04-26 5:05 pm |
N/A 2033-04-23 |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
274,922 | $0 | 274,922 (Direct) |
View |
| 2022-09-27 Exercise |
2022-09-29 8:48 pm |
N/A 2027-01-16 |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
23,653 | $0 | 37,038 (Direct) |
View |
| 2022-09-27 Exercise |
2022-09-29 8:48 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
23,653 | $16.4 | 37,038 (Direct) |
View |
| 2022-09-01 Exercise |
2022-09-06 7:00 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
4,971 | $0 | 32,360 (Direct) |
View |
| 2022-09-01 Tax Withholding |
2022-09-06 7:00 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
1,885 | $68.15 | 32,360 (Direct) |
View |
| 2022-08-01 Exercise |
2022-08-03 6:00 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
12,290 | $0 | 43,626 (Direct) |
View |
| 2022-08-01 Tax Withholding |
2022-08-03 6:00 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
2,126 | $32.4 | 43,626 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 8:52 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
63,964 | $0 | 107,963 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 8:52 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
2,763 | $0 | 107,963 (Direct) |
View |
| 2022-03-01 Tax Withholding |
2022-03-03 8:52 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
1,315 | $29.87 | 107,963 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 5:49 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
18,040 | $0 | 44,304 (Direct) |
View |
| 2022-02-01 Tax Withholding |
2022-02-03 5:49 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
4,506 | $29.33 | 44,304 (Direct) |
View |
| 2021-08-01 Exercise(A) |
2021-09-24 7:00 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
18,040 | $0 | 47,418 (Direct) |
View |
| 2021-08-01 Tax Withholding(A) |
2021-09-24 7:00 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
4,354 | $27.33 | 47,418 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 8:00 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
2,762 | $0 | 40,800 (Direct) |
View |
| 2021-09-01 Tax Withholding |
2021-09-03 8:00 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
1,370 | $29.85 | 40,800 (Direct) |
View |
| 2021-08-01 Exercise |
2021-08-03 6:19 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
18,040 | $0 | 47,418 (Direct) |
View |
| 2021-08-01 Tax Withholding |
2021-08-03 6:19 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
4,354 | $27.33 | 47,418 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 7:32 pm |
N/A 2031-02-28 |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
60,841 | $0 | 60,841 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 7:14 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
24,166 | $0 | 51,772 (Direct) |
View |
| 2021-02-01 Tax Withholding |
2021-02-03 7:14 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
5,865 | $49.49 | 51,772 (Direct) |
View |
| 2020-08-01 Exercise |
2020-08-04 9:26 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
24,164 | $0 | 57,637 (Direct) |
View |
| 2020-08-01 Tax Withholding |
2020-08-04 9:26 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
5,946 | $67.48 | 57,637 (Direct) |
View |
| 2020-06-01 Option Award |
2020-06-03 7:52 pm |
N/A N/A |
Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer |
42,400 | $0 | 42,400 (Direct) |
View |